University Of Glasgow Court

University Of Glasgow Court, doing business as University Of Glasgow, is a non-profit educational institution headquartered in Glasgow, United Kingdom, that operates as a federal grant prime recipient and subrecipient in basic research and advanced engineering development, with secondary exposure to federal contracts through Other Transaction Agreements and purchase orders. The institution competes full-and-open across federal research funding, with no set-aside designations; its federal footprint centers on research grants from defense and health agencies rather than commercial contracting.

University Of Glasgow serves 23 distinct federal agencies across 88 total awards (61% prime, 39% sub) spanning the past two decades, with recent activity concentrated in fiscal years 2024–2025. The Office of Naval Research leads by award count with 10 grants, followed by the Army (7 awards), the Department of State Bureau of Educational and Cultural Affairs (6), the National Institute of Neurological Disorders and Stroke (6), and the National Cancer Institute (5), accounting for 39% of awards. By potential value, the Army Research Development and Engineering Command anchors two awards totaling $46 thousand, though this figure masks substantial obligated funding: across all awards, the university reports $24.5 million in combined dollars obligated against a combined potential value of $105 thousand, indicating that many awards carry implicit or legacy funding values not fully captured in the current ceiling snapshot.

University Of Glasgow's prime grant portfolio emphasizes basic and applied research in acoustic fields for underwater communication and sensing, photonic crystal surface-emitting laser diodes, piezoceramics for sonar, automated chemical synthesis (the Chemputer system in collaboration with the National Center for Advancing Translational Sciences), and neuropathology of traumatic brain injury. Recent prime grants include a $100 thousand award from the Office of Naval Research (CFDA 12.300, Basic and Applied Scientific Research) for structured acoustic field investigation running through June 2029; a grant from Air Forces Europe and Africa for multi-junction buried-dielectric photonic crystal surface-emitting laser diodes (award date September 2025, completion August 2028); and an $46 thousand Other Transaction Agreement from Army Research Development and Engineering Command for MEMS gravitator development (awarded September 2025, completion September 2026). A multi-year cooperative agreement with the National Center for Advancing Translational Sciences for automated chemical synthesis began in June 2022 and runs through April 2027.

As a subrecipient, University Of Glasgow specializes in neuropathology expertise and tissue archive access, appearing repeatedly in Department of Defense and NIH grants managed by prime recipients including the University of Pennsylvania, University of Arkansas, Yale University, Washington University, and Georgetown University. The university's Glasgow Traumatic Brain Injury Archive—holding specimens from more than 1,600 acute TBI patients and 160+ chronic cases—anchors multiple sub-awards from the University of Pennsylvania for biomarker characterization and tissue analysis in support of traumatic brain injury research programs funded by NIH and DoD. Additional sub-work includes natural language processing development for the CIViC cancer genetics database (Washington University primes, multiple task orders since 2024), genomics and diagnostic support for disease surveillance in Guinea (Georgetown University prime, Defense Threat Reduction Agency funding), and medicinal chemistry synthesis supporting drug development programs (University of Virginia prime). University Of Glasgow also delivers one-off support roles as co-investigator or collaborator on grants managed by Stanford, the University of Michigan, the University of Colorado, and EcoHealth Alliance, frequently leveraging faculty expertise in neuropathology, pathogen genomics, and advanced analytical chemistry.

Four awards face completion within the next twenty-four months and present recompete opportunity. The institution's activity trajectory shows growth from four awards in 2022 to twenty in 2024, with 2025 carrying fourteen awards; 2026 to date shows one award (the ONR acoustic fields grant from July 2026). University Of Glasgow does not hold a federal contract vehicle, GWAC, or BPA; all federal work flows through competitive grants from civilian research agencies (NIH, NSF variants, ONR, Air Force Research Laboratory) and defense R&D vehicles (DTRA, Army Materiel Command). The institution performs work entirely at its Glasgow campus in the United Kingdom, with some sub-awards involving field operations in Guinea, Tanzania, and Malawi under the direction of faculty co-investigators.